Page results
-
Information for patients from overseas visiting UCLH hospitals.
-
The National Paediatric Diabetes Audit (NPDA) is asking all children and young people (8-19 years) and parents/carers (of children under 8 years old) who have received diabetes care in the past 6 months, to fill in the survey.
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
-
Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly less time in hospital, concludes a trial led by UCLH, UCL and the University of Sheffield.
-
Information for service users about the RESPOND service for refugees and asylum seekers.
-
Update about our hospital on Gray's Inn Road
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
-
This page is for patients with obesity who are waiting for scheduled surgery.
File results
-
FOI/2022/0254 - Patient treatment/ surgery
-
FOI/2022/0263 - Rheumatology prescriptions
-
FOI/2022/0267 - Performance data for the CCG2 CQUIN - Antibiotic prescribing for UTI in adults aged 16+
-
FOI/2022/0270 - Local care record/ shared care record implementation
-
FOI/2022/0274 - Patient treatment for various conditions
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0278 - Surgical tables in use at Trust
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients
-
FOI/2022/0282 - Decontamination and infection control leads; risk assessment group meetings